Iberdomide vs. Observation Post Ide-Cel CAR-T
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
Near Add Your Location
Sorting 69 by
- Not currently accepting
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
- Accepting patients
Nebraska Medicine (Bellevue Medical Center)
Bellevue, NE
- Accepting patients
- Show Principal Investigator
Nebraska Medicine (Village Pointe)
Omaha, NE
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Swedish - First Hill Campus
Seattle, WA
- Accepting patients
- Accepting patients
Swedish Cancer Institute
Issaquah, WA
- Accepting patients
Houston Methodist Hospital
Houston, TX
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.